Učitavanje...
Letrozole in the neoadjuvant setting: the P024 trial
Neoadjuvant chemotherapy trials have consistently reported lower response rates in hormone receptor-positive (HR+) breast cancer when compared with HR− cases. Preoperative endocrine therapy has therefore become a logical alternative and has gained considerable momentum from the finding that aromatas...
Spremljeno u:
Glavni autori: | , |
---|---|
Format: | Artigo |
Jezik: | Inglês |
Izdano: |
Springer US
2007
|
Teme: | |
Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2001223/ https://ncbi.nlm.nih.gov/pubmed/17912634 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10549-007-9701-x |
Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|